S. 1097: Interagency Patent Coordination and Improvement Act of 2025

S. 1097 is a federal bill in the 119th Congress. Drug companies and patent applicants will experience closer coordination between federal agencies when seeking approval for new medications. Previously, the U.S. Patent and Trademark Office and the Food and Drug Administration operated largely… See its sponsors, how members voted, and a plain-English breakdown on PolityLens.